Percutaneous Transluminal Angioplasty Markets Report, 2020-2024 & 2025-2030 Featuring Medtronic, Terumo, Cardinal Health, Boston Scientific, Teleflex, J&J, Abbott, Stryker, BD and Co, and Cook
30 sept. 2024 06h58 HE
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Percutaneous Transluminal Angioplasty (PTA) Market (2024 Edition): Analysis By Product Type (Balloon Catheters, Stents, Guidewires, Others), By...
Coronary Artery Disease Global Market Research Report 2023
24 oct. 2023 04h43 HE
|
Research and Markets
Dublin, Oct. 24, 2023 (GLOBE NEWSWIRE) -- The "Coronary Artery Disease Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global coronary artery disease...
Global Coronary Artery Disease (CAD) Market Analysis/Forecast Report 2023-2028 Featuring AstraZeneca, Novartis, Pfizer, Bristol-Myers Squibb, Merck & Co, Viatris, Sanofi, & Amgen
15 mai 2023 07h53 HE
|
Research and Markets
Dublin, May 15, 2023 (GLOBE NEWSWIRE) -- The "Coronary Artery Disease (CAD) Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Worldwide Precision Cardiology Industry to 2027 - by Offering, Sample Type, Technology, Application, End-user and Region
26 oct. 2022 07h48 HE
|
Research and Markets
Dublin, Oct. 26, 2022 (GLOBE NEWSWIRE) -- The "Global Precision Cardiology Market: Competition Forecast and Opportunities to 2027" report has been added to ResearchAndMarkets.com's offering.The...
Outlook on the Global Refractory Angina Industry to 2030 - 11-Year Forecast of Refractory Angina Epidemiology
09 sept. 2020 06h53 HE
|
Research and Markets
Dublin, Sept. 09, 2020 (GLOBE NEWSWIRE) -- The "Refractory Angina (RA) - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth...
Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device
13 déc. 2018 07h00 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that...
Avinger to Announce First Quarter 2018 Financial Results on May 14, 2018
04 mai 2018 08h00 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will...
Avinger’s Next Generation Pantheris Featured in Live Case Transmission at Charing Cross International Symposium 2018
30 avr. 2018 08h30 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that its next...
Avinger Announces First-in-Patient use of Extended Nosecone Version of Next Generation Pantheris
29 mars 2018 09h00 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that Arne...